Clinical Trial Update: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial update indicating the study of Plozasiran in adults with hypertriglyceridemia is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Hypertriglyceridemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING